Novel Prongf Mutants And Uses Thereof In The Production Of Beta-Ngf

Patent No. EP2672984 (titled "Novel Prongf Mutants And Uses Thereof In The Production Of Beta-Ngf") was filed by Scil Proteins on Dec 19, 2012. The application was issued on May 27, 2015.

Patent Summary

Patent Family

Patent family tree
Statuses, jurisdictions and citation links are shared on request.

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
CHIESI FARMACEUTICIFeb 25, 2016CAPASSO

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

EP2672984

SCIL PROTEINS
Application Number
EP12805695A
Filing Date
Dec 19, 2012
Status
Opposition Rejected
Mar 9, 2018
Publication Date
May 27, 2015